Literature DB >> 31304727

Helicobacter pylori and diabetes mellitus: a controversial relationship.

Marina Valenzano1,2, Alessandro Bisio3, Giorgio Grassi4.   

Abstract

Research on Helicobacter pylori (H. pylori), a pathogenic bacterium that is widespread among humans, is investigating the medical implications of the infection in many fields beyond gastroenterology. Because of the ubiquitous presence of the infection, there is an increasing interest in finding a relationship between this bacterium and diabetes mellitus (DM). It is not clear whether a significant relation between H. pylori and DM exists, whether the infection influences diabetes or vice versa, and the mechanisms underlying such a relationship. This review provides an analysis of new insights from studies published in more recent years. New research on this topic concentrated on the common pathogenic aspects between the bacterium and insulin resistance or autoimmunity, on the role of the bacterial infection in cardiovascular risk and whether the infection worsen glycemic outcomes in patients with DM. Research in this field still has to conclusively assess and explain the existence of a possible relationship between H. pylori and DM. Some studies have reached antithetic conclusions. Unless more robust data from studies using consistent research methods become available in the near future, people with diabetes should be compared to the general population when it comes to investigating and treating the presence of H. pylori.

Entities:  

Year:  2019        PMID: 31304727     DOI: 10.23736/S0391-1977.19.03021-9

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  4 in total

1.  Comparison between liraglutide alone and liraglutide in combination with insulin on osteoporotic rats and their effect on bone mineral density.

Authors:  Kai Chen; Ruofei Wu; Bin Mo; Xuegang Yan; Dongjun Shen; Maoxi Chen
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-03-01       Impact factor: 2.041

Review 2.  Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems.

Authors:  Li Wang; Zheng-Min Cao; Li-Li Zhang; Xin-Can Dai; Zhen-Ju Liu; Yi-Xian Zeng; Xin-Ye Li; Qing-Juan Wu; Wen-Liang Lv
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

3.  Evaluation of the Direct Economic Cost per Eradication Treatment Regimen against Helicobacter pylori Infection in Greece: Do National Health Policy-Makers Need to Care?

Authors:  Christos Liatsos; Apostolis Papaefthymiou; Nikolaos Kyriakos; Marios Giakoumis; Jannis Kountouras; Michail Galanopoulos; Periklis Apostolopoulos; Sotirios D Georgopoulos; Christos Mavrogiannis; Aristomenis K Exadaktylos; David Shiva Srivastava; Theodore Rokkas; Michael Doulberis
Journal:  Medicina (Kaunas)       Date:  2020-03-18       Impact factor: 2.430

Review 4.  From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?

Authors:  Giovanni Vitale; Alessandra Dicitore; Luigi Barrea; Emilia Sbardella; Paola Razzore; Severo Campione; Antongiulio Faggiano; Annamaria Colao; Manuela Albertelli; Barbara Altieri; Filomena Bottiglieri; Federica De Cicco; Sergio Di Molfetta; Giuseppe Fanciulli; Tiziana Feola; Diego Ferone; Francesco Ferraù; Marco Gallo; Elisa Giannetta; Federica Grillo; Erika Grossrubatscher; Elia Guadagno; Valentina Guarnotta; Andrea M Isidori; Andrea Lania; Andrea Lenzi; Fabio Lo Calzo; Pasquale Malandrino; Erika Messina; Roberta Modica; Giovanna Muscogiuri; Luca Pes; Genoveffa Pizza; Riccardo Pofi; Giulia Puliani; Carmen Rainone; Laura Rizza; Manila Rubino; Rosa Maria Ruggieri; Franz Sesti; Mary Anna Venneri; Maria Chiara Zatelli
Journal:  Rev Endocr Metab Disord       Date:  2020-09-15       Impact factor: 9.306

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.